Voices
IASLC Named Ruth Sudha Moses as a Adi F. Gazdar Fellowship Recipient
Ruth Sudha Moses/LinkedIn

IASLC Named Ruth Sudha Moses as a Adi F. Gazdar Fellowship Recipient

International Association for the Study of Lung Cancer (IASLC) shared on LinkedIn:

“Congratulations to Ruth Sudha Moses, a recipient of the IASLC Adi F. Gazdar Fellowship!

Her project, ‘Lorlatinib Administered with Oral Azole for ALK-Positive Lung Cancer: A Phase II Open-Label Study‘, will investigate this treatment approach for patients with ALK-positive lung cancer.

We’re proud to support researchers pursuing work that could help advance lung cancer treatment and improve care for patients.”

IASLC

You can also read ‘Chris Boshoff: Lorlatinib’s Durable Impact in ALK-Positive NSCLC‘

IASLC

Adi F. Gazdar Fellowship Recipient ALK-positive lung cancer cancer IASLC IASLC Adi F. Gazdar Fellowship International Association for the Study of Lung Cancer lorlatinib Lung cancer OncoDaily Oncology Oral Azole Ruth Sudha Moses